1.
Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricula...
by Grewal, Jasmine, MD
The American journal of cardiology, 2008, Vol.102 (6), p.733-737
2.
Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis
by Rego-Pérez, I
Annals of the rheumatic diseases, 2010-05, Vol.69 (5), p.910-917
3.
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis
by de Seny, Dominique
Annals of the Rheumatic Diseases, 2011-06, Vol.70 (6), p.1144-1152
4.
Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial...
by Björklund, E
Heart (British Cardiac Society), 2006-06, Vol.92 (6), p.735-740
5.
Usefulness of Biomarkers for Predicting Long-Term Mortality in Patients With Diabetes Mellitus and Non–ST-Elevation Acute Coronary Syndromes (A GUSTO IV Substudy)
by James, Stefan K
The American journal of cardiology, 2006, Vol.97 (2), p.167-172
6.
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
by Solomon, Scott D, Prof Dr
The Lancet (British edition), 2012-10-20, Vol.380 (9851), p.1387-1395
7.
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
by Pavo, Noemi
Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1874-1880
8.
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
by Felker, G. Michael, MD, MHS
The American heart journal, 2009, Vol.158 (3), p.422-430
9.
Trimethylamine N-oxide and prognosis in acute heart failure
by Suzuki, Toru
Heart (British Cardiac Society), 2016-06, Vol.102 (11), p.841
10.
Higher Serum Undercarboxylated Osteocalcin and Other Bone Turnover Markers Are Associated With Reduced Diabetes Risk and Lower Estradiol Concentrations in Older Men
by Yeap, Bu B
The journal of clinical endocrinology and metabolism, 2015-01, Vol.100 (1), p.63-71
11.
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2: Prevention of Angiotensin II–Dependent Hypertension
by Wysocki, Jan
Hypertension (Dallas, Tex. 1979), 2010-01, Vol.55 (1), p.90-98
12.
An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β(1–42) using a microporous gold nanostructure
by Negahdary, Masoud
Mikrochimica acta (1966), 2019-11-12, Vol.186 (12), p.766-766
13.
Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF
by Kang, Si-Hyuck
Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1881-1888
14.
Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension
by Andreassen, Arne K
Heart (British Cardiac Society), 2013-10, Vol.99 (19), p.1415-1420
15.
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis)
by Gupta, Deepak K
The American journal of cardiology, 2017-09-15, Vol.120 (6), p.1008-1015
16.
Practical Approaches for Whole-Genome Sequence Analysis of Heart- and Blood-Related Traits
by Morrison, Alanna C
American journal of human genetics, 2017-02-02, Vol.100 (2), p.205-215
17.
Determinants of the Impaired Secretion of Glucagon-Like Peptide-1 in Type 2 Diabetic Patients
by Toft-Nielsen, Mai-Britt
The journal of clinical endocrinology and metabolism, 2001-08, Vol.86 (8), p.3717-3723
18.
High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes
by Boonman-de Winter, L. J. M
Diabetologia, 2012-05-18, Vol.55 (8), p.2154-2162
19.
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboratio...
by Salah, Khibar
Heart (British Cardiac Society), 2014-01, Vol.100 (2), p.115-125
20.
Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD
by Chang, Catherina L
Thorax, 2011-09, Vol.66 (9), p.764-768
